Sandu Pharmaceuticals Ltd Share Price

Sandu Pharma.
Small Cap | Pharmaceuticals
₹ 39.5 -0.7 (-1.74%)
Last updated: 05-Dec-2025 , 16:01:35

Sandu Pharmaceuticals Ltd Live Price Chart

Low: ₹39.03 High: 40

Sandu Pharmaceuticals Ltd Technicals

Current Price
₹ 39.5 -0.7 (-1.74%)
EMASMA
20 Day ₹ 40.590
50 Day ₹ 42.826
100 Day ₹ 45.196
200 Day ₹ 48.363
20 Day ₹ 40.767
50 Day ₹ 43.230
100 Day ₹ 45.903
200 Day ₹ 48.630

Sandu Pharmaceuticals Ltd Performance

Previous Close ₹ 40.2
High ₹ 40
Volume 2052
52W Range ₹ 37 - ₹ 62.8
Open ₹ 40
Low ₹ 39.03
Market Cap 36.52 Cr

Sandu Pharmaceuticals Ltd Fundamentals

ROCE 5.391
P/E Ratio 23.370
P/B Ratio 1.130
Industry P/E 1.130
Debt to Equity 40.401
ROE 3.858
EPS 1.690
Dividend Yield 2.030
Book Value 34.849
Face Value 10.000

Sandu Pharmaceuticals Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 67.3599 67.702 65.6762 65.5833 58.9488
Total Expenses 65.2041 65.6298 63.4561 63.2668 57.2679
Profit After Tax 1.5489 1.4607 1.5239 1.5893 1.0925

Sandu Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings 42.902 %
FIIs 0.000 %
DIIs 0.005 %
MutualFund 0.000 %
Retail 36.771 %
Others - 20.322 %

About Sandu Pharmaceuticals Ltd

History of Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97. There ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Amrutanjan Health Care Ltd ₹ 544.1 - ₹ 842.9 659.9 33.42
Bliss GVS Pharma Ltd ₹ 108.12 - ₹ 190.97 170.1 23.08
Biofil Chemicals & Pharmaceuticals Ltd ₹ 32.6 - ₹ 67.69 34.9 19.83
Marksans Pharma Ltd ₹ 162 - ₹ 358.55 183.5 34.58
Syncom Formulations (India) Ltd ₹ 14.1 - ₹ 23.87 15.07 22.55

FAQs on Sandu Pharmaceuticals Ltd

1. Can I buy Sandu Pharmaceuticals Ltd from PL Capital? ›

Yes, you can invest in Sandu Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Sandu Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Sandu Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Sandu Pharmaceuticals Ltd pay dividends? ›

Yes, Sandu Pharmaceuticals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Sandu Pharmaceuticals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Sandu Pharmaceuticals Ltd ? ›

As of 05-12-2025 the share price for Sandu Pharmaceuticals Ltd. is 39.5 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Sandu Pharmaceuticals Ltd ? ›

The 52-week high and low of Sandu Pharmaceuticals Ltd share price is ₹ 37 - ₹ 62.8 as of 05-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source